Immediate Impact
6 standout
Citing Papers
Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil/Caelyx): an updated analysis and future perspective
2025 Standout
Mechanisms of metastatic colorectal cancer
2024 Standout
Works of M. Daugherity being referenced
Complement as Prognostic Biomarker and Potential Therapeutic Target in Renal Cell Carcinoma
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| M. Daugherity | 13 | 17 | 9 | 4 | 44 | |||
| X. Zhao | 21 | 4 | 5 | 5 | 52 | |||
| Lei Huo | 4 | 5 | 6 | 4 | 36 | |||
| Y. Unno | 5 | 20 | 4 | 5 | 48 | |||
| Eugene P. Chambers | 12 | 12 | 6 | 169 | ||||
| Hester van Willigenburg | 8 | 7 | 5 | 47 | ||||
| Huiying Sun | 6 | 5 | 3 | 4 | 45 | |||
| P.R.S. Wright | 8 | 5 | 2 | 6 | 43 | |||
| Tariq Haddad | 15 | 19 | 4 | 165 | ||||
| X. R. Qi | 18 | 2 | 8 | 4 | 36 | |||
| Pilar Baldominos | 15 | 3 | 3 | 41 |
All Works
Login with ORCID to disown or claim papers
Loading papers...